We therefore conclude that RASSF1A executes its tumor-suppressor functions in ERα-driven breast cancer cells through LATS1 and LATS2, and that mutual interaction between RASSF1A and LATS1 and LATS2 are important for the suppression of ERα+ breast cancer. Here, ESR1 is linked to breast carcinoma.